Transactions

Deal Showcase

About Transactions

Castle Biosciences, Inc. Initial Public Offering

Published: July 2019
Biopharma DNA strand composition

More Transactions

$125 Million
Joint Bookrunner
Follow-On
February 2023
$119 Million
Joint Bookrunner
Follow-On
October 2021
$150 Million
Joint Bookrunner
Follow-On
December 2023
$35 Million
Exclusive Financial Advisor
Series C Financing Led by MultiPlan Corporation
June 2022
View all Transactions

Featured Insights

VIEW ADDITIONAL INSIGHTS
Banner desktop

Join Our Mailing List

Receive CPE newsletters, reports, and correspondence in your inbox

CPE Contact

Complete the form below to request to be added to the distribution list for the Center for Pharmacoeconomics (CPE). “*” indicates required fields

This field is for validation purposes and should be left unchanged.
Consent(Required)